亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

岳陽市嘉誠生物科技有限公司銷售部  

高效氯氟氰菊酯,匹可硫酸鈉,溴蟲睛,3,4,5一三甲氧基肉桂酸,2,4一二羥基苯甲酸,三乙脂,烯丙基硫脲

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:熊先生
  • 電話:0730-8705981
  • 郵件:gcns08@ycgmp.com
  • 傳真:0730-8705981
  • QQ:2355779402
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 廠家供應奮乃靜原料
廠家供應奮乃靜原料
單價 面議對比
詢價 暫無
發貨 湖南岳陽市付款后3天內
品牌 南箭
過期 長期有效
更新 2019-06-27 09:08
 
詳細信息
 奮乃靜
中文同義詞:奮乃靜;4-[3-(2氯吩噻嗪-10-基)丙基]-1-呱嗪乙醇;過二苯嗪;氯吩嗪;2-氯-10-[3-(4-甲基哌嗪-1-基)丙基]吩噻嗪;丙氯拉嗪;甲哌氯丙嗪;奮乃靜,丙氯拉嗪
英文名稱:Prochlorperazine
英文同義詞:10H-Phenothiazine, 2-chloro-10-[3-(4-methyl-1-piperazinyl)propyl]-;2-Chloro-10-(3-(1-methyl-4-piperazinyl)-propyl)-phenothiazine;2-chloro-10-(3-(4-methyl-1-piperazinyl)propyl)-10h-phenothiazin;2-chloro-10-(3-(4-methyl-1-piperazinyl)propyl)-phenothiazin;2-Chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine;2-Chloro-10-[3-(4-methyl-1-piperazinyl)propyl]-10H-phenothiazine;3-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)phenothiazine;3-chloro-10-[3-(4-methyl-1-piperazinyl)propyl]phenothiazine
CAS號: 58-38-8
分子式: C20H24ClN3S
分子量: 373.94
 
醫藥中間體
奮乃靜 用途
適應癥 臨床適用于具有焦慮緊張、幻覺妄想、情緒不穩及思維障礙等癥狀的精神病。
©2025 岳陽市嘉誠生物科技有限公司銷售部 版權所有   技術支持:化工網   訪問量:12074  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |